Disc Medicine, Inc.
IRON
$70.03
$1.502.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -86.31% | -105.49% | -134.30% | -109.65% | -26.48% |
| Total Depreciation and Amortization | 345.00% | 888.89% | 690.91% | -22.73% | -23.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 168.59% | 268.61% | 344.41% | 90.87% | -0.71% |
| Change in Net Operating Assets | 12.72% | 1,785.74% | -14.51% | -96.07% | -5.56% |
| Cash from Operations | -50.42% | -57.04% | -175.32% | -211.30% | -23.15% |
| Capital Expenditure | -- | 95.55% | -425.00% | -1,300.00% | -1,170.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 121.45% | -22,711.98% | 169.71% | 123.54% | -- |
| Cash from Investing | 121.39% | -15,530.65% | 169.68% | 123.52% | -406,814.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.28% | 17,536.11% | 2,620.19% | -99.48% | 1,377.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 436.68% | -- | -- | -- |
| Cash from Financing | -99.31% | 652.43% | 2,620.19% | -99.48% | 1,436.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.80% | -24,413.37% | 115.14% | 107.53% | -292.65% |